Trader 📈 bio-hacker 🧬 and weight lifter 💪🏼 Peptides are the future. Disclosure: Opinions only, not investment advice. DYOR. High risk, High reward stocks.

Joined November 2024
90 Photos and videos
David retweeted
$AZN $LEXX AstraZeneca and Zealand Pharma are in an existential commercial crisis right now with their announced catastrophic tolerability in their GLP1 studies. Nausea, vomiting and diarrhea. High drops out rates. @AstraZeneca As speculated, the mystery global pharma in the MTA is @EliLillyandCo or @novonordisk they should be worried about another player swooping in. 🔥 $NVO / $LLY
1
2
230
$LEXX Quote from CEO Richard Christopher in video regarding MTA: “what I can tell you is that they are a worldwide global glp1 player….We have now completed two distinct animals studies utilizing our partners API along with our dehydraTECH technology” Key words “utilizing our partners API” 👀 $NVO / $LLY
69
David retweeted
In bed with one of the big ones . Commercial deal is coming and then… Kaaabooom 💥💥💥 $LEXX #GLP1 #PHARMA
$LEXX Quote from CEO Richard Christopher in video regarding MTA: “what I can tell you is that they are a worldwide global glp1 player….We have now completed two distinct animals studies utilizing our partners API along with our dehydraTECH technology” Key words “utilizing our partners API” 👀 $NVO / $LLY
1
2
145
David retweeted
$AZN $LEXX AstraZeneca and Zealand Pharma are in an existential commercial crisis right now with their announced catastrophic tolerability in their GLP1 studies. Nausea, vomiting and diarrhea. High drops out rates. @AstraZeneca As speculated, the mystery global pharma in the MTA is @EliLillyandCo or @novonordisk they should be worried about another player swooping in. 🔥 $NVO / $LLY
2
1
394
David retweeted
$LEXX Quote from CEO Richard Christopher in video regarding MTA: “what I can tell you is that they are a worldwide global glp1 player….We have now completed two distinct animals studies utilizing our partners API along with our dehydraTECH technology” Key words “utilizing our partners API” 👀 $NVO / $LLY
$LEXX @LexariaBioCorp Animal & Human GLP-1 Studies Continue buff.ly/Q3Bl8KH by @vanjohn10
2
3
723
David retweeted
$LLY / $LEXX “utilizing our partners api” 🔥. Global commercial deal incoming?
$LEXX Quote from CEO Richard Christopher in video regarding MTA: “what I can tell you is that they are a worldwide global glp1 player….We have now completed two distinct animals studies utilizing our partners API along with our dehydraTECH technology” Key words “utilizing our partners API” 👀 $NVO / $LLY
2
2
278
$LEXX 🤝 $LLY / $NVO. “discuss strategic planning for the asset(s) under consideration.”
$LEXX @LexariaBioCorp Animal & Human GLP-1 Studies Continue buff.ly/Q3Bl8KH by @vanjohn10
1
1
177
$LEXX 👀 looks like @novonordisk had a BIG problem. $NVO
$NVO R&D event over the weekend. SNAC does not work with new generation drugs. 👀 ➡️ $LEXX ‼️ seekingalpha.com/article/491…
1
221
$LEXX 👀 🤝 $AZN
$AZN 👀 $LEXX “Gastrointestinal side effects were common at the highest dose, including nausea (55%), constipation (41%), diarrhea (35%), and vomiting (27%), although AstraZeneca said discontinuation rates were low.”
1
105
$AZN $ZEAL AstraZeneca and Zealand Pharma are in an existential commercial crisis right now with their announced catastrophic tolerability in their GLP1 studies. Nausea, vomiting and diarrhea. High drops out rates. @AstraZeneca Hard to imagine they are not knocking on @LexariaBioCorp door right now. $LEXX dehydraTECH 👀
1
4
307
$LEXX 🤝 $AZN
$AZN 👀 $LEXX “Gastrointestinal side effects were common at the highest dose, including nausea (55%), constipation (41%), diarrhea (35%), and vomiting (27%), although AstraZeneca said discontinuation rates were low.”
119
David retweeted
$LEXX don’t sleep mate! Will be the next $LQDA , Unique new MOA Established drugs >> 🎯🎯 exclusive MTA ongoing $NVO $LLY ? @LexariaBioCorp
$LEXX new study with heavy focus on Retatrutide by @EliLillyandCo $LLY Also being tested is Amycretin by @novonordisk $NVO Lexaria is currently in a twice extended exclusive MTA with a global pharma company speculated to be Lilly or Novo. lexariabioscience.com/2026/0…
1
1
732
David retweeted
$LEXX new study with heavy focus on Retatrutide by @EliLillyandCo $LLY Also being tested is Amycretin by @novonordisk $NVO Lexaria is currently in a twice extended exclusive MTA with a global pharma company speculated to be Lilly or Novo. lexariabioscience.com/2026/0…
1
2
302
$NVO R&D event over the weekend. SNAC does not work with new generation drugs. 👀 ➡️ $LEXX ‼️ seekingalpha.com/article/491…
1
170